CD200(+) fibroblasts prime the immunoregulatory function of granulocytic myeloid-derived suppressor cells in inflammatory arthritis.

CD200(+) fibroblasts enhance the immunoregulatory function of G-MDSCs in inflammatory arthritis, with treatment modulating disease severity in mice.

• Why it matters: Understanding how the joint tissue microenvironment influences G-MDSC function could reveal new therapeutic targets for inflammatory arthritis, as their regulation appears tissue-specific.
• What they did: Researchers analyzed single-cell RNA sequencing data and used mouse models to investigate the interaction between CD200(+) fibroblasts and G-MDSCs, including treatments with CD200R1 agonists and blockers, and adoptive cell transfer.
• The result: Findings show that CD200(+) fibroblasts promote G-MDSC immunoregulatory activity, with CD200R1 agonists enhancing PD-L1 expression and CD200 blockade impairing G-MDSC differentiation, thereby affecting disease severity.